Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

An interview with Kitty van Weezenbeek, Director of Surveillance, Prevention and Control of AMR for the World Health Organistion (WHO) AMR division.

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Alliance 12.11.2024 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

November 13, 2024

Elotuzumab Misses Mark Again as Frontline Treatment for Multiple Myeloma

Elotuzumab (Empliciti) failed for a third time to improve progression-free survival (PFS) in newly diagnosed multiple myeloma when added to standard therapy, a large randomized

February 21, 2024

INTEGRA Biosciences drives down transport emissions with European production facility

INTEGRA Biosciences has completed construction of its new campus and pipette tip manufacturing plant at its headquarters in Zizers, Switzerland.

March 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.